• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Placenta . The placental pathology in Coronavirus disease 2019 infected mothers and its impact on pregnancy outcome

tetano

Editor, Senior Moderator
Placenta


. 2022 Jul 19;127:1-7.
doi: 10.1016/j.placenta.2022.07.009. Online ahead of print.
The placental pathology in Coronavirus disease 2019 infected mothers and its impact on pregnancy outcome


Bharti Joshi[SUP] 1 [/SUP], Anadeep Chandi[SUP] 2 [/SUP], Radhika Srinivasan[SUP] 3 [/SUP], Shiv Sajan Saini[SUP] 4 [/SUP], G R V Prasad[SUP] 5 [/SUP], G D Puri[SUP] 6 [/SUP], Ashish Bhalla[SUP] 7 [/SUP], Vanita Suri[SUP] 8 [/SUP], Rashmi Bagga[SUP] 9 [/SUP]



Affiliations

Abstract

Introduction: This study aims at observing placental pathologies in COVID-19 infected women, and analyzing its impact on pregnancy outcome.
Method: This is a descriptive-analytical study done at a tertiary centre of Northern India. All COVID-19 positive pregnant women with gestational age ≥20 weeks, with placental histopathological reporting, were included in this study. A total of 173 COVID-19 pregnant women were included in the study.
Results: Placental abnormalities were noticed in 49·16% of total 179 placentae examined. Maternal vascular malperfusion (27·93%) was the most observed placental pathology followed by villous fibrin deposits (22·90%), fetal vasculopathy (16·75%), and acute inflammation (6·70%). Stillbirths were 22 and NICU admissions were seen in 50 neonates. Abnormal placental abnormalities led to higher stillbirths (p value 0·011) and lower Apgar scores at 1 and 5 min (p-value 0·028; p-value 0·002, respectively). Intervillous fibrin deposits had higher risk associated with lower Apgar score at 1 and 5 min [RR 2·05 (95% CI 1·21-3·48, p-value 0·010) and RR 5·52 (95% CI 2·58-11·81, p-value <0·001), respectively]. RP clot/hemorrhage was also associated with lower Apgar score at 1 and 5 min [RR 2·61 (95% CI 1·52-4·49, p-value 0·002) and RR 3.54 (95% CI 1·66-7·55, p-value 0·001), respectively].
Discussion: Placental abnormalities in COVID-19 infection were associated with significant higher incidence of unexplained stillbirths, and lower Apgar scores. Although, this is the largest descriptive-analytical study done so far, comparative studies are required to draw a clear conclusion regarding the impact of COVID-19 infection on human placenta and its effect on pregnancy outcomes.

Keywords: COVID-19; Infectious disease; Neonatal outcome; Obstetric complication; Placental pathology; Pregnancy outcome; SARS-CoV-2; Stillbirths.
 
Back
Top Bottom